Guggenheim resumed coverage on Tyra Biosciences with a new price target

Nov 20, 2026
guggenheim-resumed-coverage-on-tyra-biosciences-with-a-new-price-target

Guggenheim resumed coverage of Tyra Biosciences with a rating of Buy and set a new price target of $55.00 Real-time TYRA news, filings and analyst ratings on…

Leave a comment